LyondellBasell Industries NV (LYB)
NYSE
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 18.677 | 20.628 | 17.173 | 10.662 | 4.104 | 18.262 | 9.779 | 4.633 |
Return on Equity (%) | 74.584 | 71.85 | 50.466 | 35.766 | 18.359 | 69.674 | 30.1 | 13.893 |
Return on Invested Capital (%) | 41.988 | 36.589 | 33.882 | 22.399 | 15.977 | 42.324 | 23.226 | 14.122 |
Operating Margin (%) | 20.483 | 18.019 | 14.208 | 12.059 | 6.437 | 19.067 | 9.608 | 6.702 |
Net Profit Margin (%) | 14.315 | 14.639 | 11.888 | 8.885 | 4.793 | 14.446 | 7.341 | 4.361 |
Book Value Per Share | 11.439 | 19.247 | 19.343 | 14.601 | 14.092 | 30.1 | 32.423 | 33.419 |
Earnings Per Share | 10.375 | 12.836 | 12.382 | 9.302 | 4.042 | 20.693 | 11.66 | 5.529 |
Cash Per Share | 2.341 | 4.002 | 1.105 | 2.816 | 5.787 | 4.934 | 7.334 | 10.888 |
Working Capital Per Share | 10.751 | 16.456 | 10.524 | 11.881 | 17.149 | 18.204 | 17.684 | 18.95 |
Operating Profit Per Share | 19.04 | 20.577 | 20.634 | 20.697 | 15.73 | 38.005 | 25.74 | 22.01 |
EBIT Per Share | 14.053 | 14.55 | 13.902 | 11.29 | 3.59 | 25.345 | 14.07 | 6.598 |
EBITDA Per Share | 14.053 | 14.55 | 13.902 | 11.29 | 3.59 | 25.345 | 14.07 | 6.598 |
Free Cash Flow Per Share | 13.261 | 13.678 | 15.135 | 12.409 | 4.62 | 21.724 | 11.786 | 3.985 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 404,05M | 394,51M | 375,7M | 333,48M | 334,02M | 329,54M | 325,72M | 324,48M |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 325,72M | 325,47M | 324,52M | 324,36M | 324,48M | 325,37M | 325,08M | 324,75M |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | 7.397 | N/A | N/A | N/A | 7.285 | N/A | N/A |
Net Profit Margin (%) | N/A | 4.606 | N/A | N/A | N/A | 4.746 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 23,7B |
Ratio cours/bénéfice | 13,31 |
Ratio prix/ventes | 0,58 |
Ratio prix/liquidités | 6,76 |
Ratio prix/valeur comptable | 1,85 |
Rendement de dividende | - |
Actions en circulation | 324,76M |
Volume moyen (1 semaine) | 3,38M |
Volume moyen (1 mois) | 3,36M |
Variation sur 52 semaines | -23,73% |
Plus haut sur 52 semaines | 107,02 |
Plus bas sur 52 semaines | 72,96 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales